Association between diet quality and measures of body adiposity using the Rate Your Plate survey in patients presenting for coronary angiography

Publisher： John Wiley & Sons Inc

E-ISSN： 1932-8737|41|1|126-130

ISSN： 0160-9289

Source： Clinical Cardiology, Vol.41, Iss.1, 2018-01, pp. : 126-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

BackgroundDiet is a modifiable risk factor for cardiovascular disease; however, dietary patterns are historically difficult to capture in the clinical setting. Healthcare providers need assessment tools that can quickly summarize dietary patterns. Research should evaluate the effectiveness of these tools, such as Rate Your Plate (RYP), in the clinical setting.

HypothesisRYP diet quality scores are associated with measures of body adiposity in patients referred for coronary angiography.

MethodsPatients without a history of coronary revascularization (n = 400) were prospectively approached at a tertiary medical center in New York City prior to coronary angiography. Height, weight, and waist circumference (WC) were measured; body mass index (BMI) and waist‐to‐height ratio (WHtR) were calculated. Participants completed a 24‐question RYP diet survey. An overall score was computed, and participants were divided into high (≥58) and low (≤57) diet quality groups.

ResultsParticipants in the high diet quality group (n = 98) had significantly lower measures of body adiposity than did those in the low diet quality group (n = 302): BMI (P < 0.001), WC (P = 0.001), WHtR (P = 0.001). There were small but significant inverse correlations between diet score and BMI, WC, and WHtR (P < 0.001). These associations remained significant after adjustment for demographics, tobacco use, and socioeconomic factors.

ConclusionsHigher diet quality scores are associated with lower measures of body adiposity. RYP is a potential instrument to capture diet quality in a high‐volume clinical setting. Further research should evaluate the utility of RYP in cardiovascular risk‐factor control.